Axonics

Axonics Quick Ratio

Quick Ratio (Acid Test) of Axonics (AXNX) as of Nov 19, 2026.

Quick Ratio

-

Last updated:

Quick Ratio (Acid Test) of Axonics is 2026 - . Quick Ratio (Acid Test) of Axonics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Axonics since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Axonics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Axonics

All Key Metrics — Axonics